Ann Arbor, MI, United States of America

Ted C Annis

USPTO Granted Patents = 1 


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovator Behind Pathogen Inactivation: Ted C. Annis

Introduction

Ted C. Annis is an accomplished inventor based in Ann Arbor, MI, known for his significant contributions to the field of microbiology through innovative compositions aimed at inactivating pathogenic microorganisms. With a focus on low-toxicity solutions, his work has the potential to revolutionize public health and disease prevention.

Latest Patents

Annis holds a patent for "Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof." This patent details nanoemulsion compositions that demonstrate broad-spectrum inactivation of microorganisms while being safe for use. The formulation includes an aqueous phase, an oil phase comprising an oil and an organic solvent, along with one or more surfactants. Such compositions are pivotal for developing safer alternatives in combating infectious diseases.

Career Highlights

Annis is currently affiliated with Nanobio Corporation, where he applies his innovative ideas alongside a team of skilled researchers. The company's focus on nanotechnology positions it uniquely in the industry, aiming to leverage the properties of nanoemulsions to widen the scope of antimicrobial interventions.

Collaborations

Throughout his career, Annis has collaborated with notable colleagues, including James R. Baker, Jr. and Tarek Hamouda. These partnerships have further enriched his research and have contributed to the development of effective solutions for health-related challenges.

Conclusion

Ted C. Annis stands out as a forward-thinking inventor whose work on nanoemulsions is setting new standards for pathogen inactivation. His dedication and collaboration with talented peers like Baker and Hamouda at Nanobio Corporation exemplify the innovative spirit needed to tackle some of today's critical health issues. As research continues, Annis's contributions will likely play a crucial role in enhancing the safety and efficacy of antimicrobial products.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…